Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Lithium-related genetics of bipolar disorder.

Detera-Wadleigh SD.

Ann Med. 2001 May;33(4):272-85. Review.

PMID:
11405549
2.

Lithium and synaptic plasticity.

Salinas PC, Hall AC.

Bipolar Disord. 1999 Dec;1(2):87-90. Review.

PMID:
11252664
3.

Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.

Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G.

J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6. Review.

PMID:
10073385
4.

The Wnt signaling pathway in bipolar disorder.

Gould TD, Manji HK.

Neuroscientist. 2002 Oct;8(5):497-511. Review.

PMID:
12374432
5.

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.

Ikonomov OC, Manji HK.

Am J Psychiatry. 1999 Oct;156(10):1506-14. Review.

PMID:
10518159
6.

Endophenotypes in bipolar disorder.

Lenox RH, Gould TD, Manji HK.

Am J Med Genet. 2002 May 8;114(4):391-406. Review. Erratum in: Am J Med Genet 2002 Jul 8;114(5):592.

PMID:
11992561
7.

Overview of the mechanism of action of lithium in the brain: fifty-year update.

Lenox RH, Hahn CG.

J Clin Psychiatry. 2000;61 Suppl 9:5-15. Review.

PMID:
10826655
8.

Judging a protein by more than its name: GSK-3.

Woodgett JR.

Sci STKE. 2001 Sep 18;2001(100):re12. Review.

PMID:
11579232
9.
11.
12.

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

Hardt SE, Sadoshima J.

Circ Res. 2002 May 31;90(10):1055-63. Review.

13.

Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.

Einat H, Manji HK.

Biol Psychiatry. 2006 Jun 15;59(12):1160-71. Epub 2006 Feb 2. Review.

PMID:
16457783
14.

Regulation of protein kinases in insulin, growth factor and Wnt signalling.

Pearl LH, Barford D.

Curr Opin Struct Biol. 2002 Dec;12(6):761-7. Review.

PMID:
12504681
15.

New steps in the Wnt/beta-catenin signal transduction pathway.

Sakanaka C, Sun TQ, Williams LT.

Recent Prog Horm Res. 2000;55:225-36. Review.

PMID:
11036939
16.

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Gould TD, Manji HK.

Neuropsychopharmacology. 2005 Jul;30(7):1223-37. Review.

17.

[Mechanism of action of lithium: intracellular signaling pathways].

Zorrilla Zubilete M.

Vertex. 2003 Mar-May;14(51):45-52. Review. Spanish.

PMID:
12690409
18.

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.

Manoukian AS, Woodgett JR.

Adv Cancer Res. 2002;84:203-29. Review.

PMID:
11883528
19.

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Chiu CT, Chuang DM.

Pharmacol Ther. 2010 Nov;128(2):281-304. doi: 10.1016/j.pharmthera.2010.07.006. Epub 2010 Aug 10. Review.

20.

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.

Gurvich N, Klein PS.

Pharmacol Ther. 2002 Oct;96(1):45-66. Review.

PMID:
12441177

Supplemental Content

Support Center